Skip to main content
Equibles
PRCT logo

PRCT · PROCEPT BioRobotics Corp

Track PRCT — free

Use PRCT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PRCT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$21.65 -0.30 (-1.37%) At close · Aug 14
Market Cap
$1.24B
Shares
57.27M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$21.65 Open$22.10 Day$21.40–22.10 52W close$16.69–41.59 Avg vol 30d1.8M Short int7.1M · 12.4% float · 5.1d Short vol49% Last earningsAug 4, 2026 DataSep 2021–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −19%
      below
      Price vs 50-day avg +2%
      above
      RSI (14) 57
      neutral
      MACD trend Positive
      52-week position 20%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +13%
      trailing
      6-month return −21%
      trailing
      YTD return −31%
      this year
      Relative strength −35%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $21 › 200d $27 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +37 funds added
      Insider flow Accumulating
      Net +$469.8K over 90 days · 75% sells
      Short interest Falling
      12.38% of float · ▼ -8.5% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      253 holders — mid 3-yr range
      Squeeze score 67
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +37%
      Y/Y
      Gross margin 64%
      expanding
      EPS growth +2%
      Y/Y
      Free cash flow $-58.3M
      Balance sheet $234.9M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 63%
      annualized · 1-yr
      Max drawdown −60%
      past year
      ATR 6.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 2
      Latest guidance · from the 8-K filed Aug 4, 2026
      Revenue · full year 2026 $390M – $410M
      Gross margin · full year 2026 65%
      Adjusted EBITDA loss · full year 2026 Non-GAAP $-35M – $-30M
      Prior guidance period ended · from the 8-K filed Feb 25, 2026
      Total revenue · first quarter of 2026 $79M – $82M
      Guided vs delivered · last 2 settled
      Revenue for the full year 2025 full year 2025
      guided $325.5M
      $308.05M Miss −5.4%
      Total revenue full year 2024
      guided $210M
      $224.5M Beat +6.9%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −19% Bearish
      Price vs 50-day avg
      +2% Bullish
      RSI (14)
      57 Neutral
      MACD trend
      Positive Bullish
      52-week position
      20% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $21 › 200d $27 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +37 funds added
      Insider flow Accumulating
      Net +$469.8K over 90 days · 75% sells
      Short interest Falling
      12.38% of float · ▼ -8.5% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      253 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $17 Now $22 · 20% Range high $42
      vs 200-day avg -19% vs 50-day avg +2%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      U.S. install base 765 March 31, 2026 —
      Systems sold 65 fourth quarter of 2025 —
      U.S. handpieces sold 9,400 fourth quarter of 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      PRCT
      PROCEPT BioRobotics Corp
      this stock
      		$1.24B -31.2% +37.2% — 12.4%
      ABT
      Abbott Laboratories
      		 $193.78B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      		 $130.11B -3.5% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      		 $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      		 $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      253
      % held
      97.0%
      Net QoQ
      -1.0M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      198
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      7.1M
      Days to cover
      5.1d
      Change
      -662.2K sh
      View
      Short Volume
      Short vol %
      49%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      26.2K
      Value
      $516.7K
      As of
      Jul 10, 2026
      View
      Off-Exchange
      Off-exchange %
      41.3%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$469.8K
      Buyers / Sellers
      1 / 3
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $308.1M
      Net income (FY)
      $-95.6M
      EPS diluted
      $-1.72
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 5, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $10.2K
      Shares
      358
      Filed
      Jun 8, 2026
      View
      Exempt Offerings
      Offering
      $85.0M
      Filed
      Jun 21, 2021
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 4, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      PRCT +6.1% +12.6% -20.9% +16.3% -31.2%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +5.7% +8.2% -34.6% +12.4% -45.0%
      Key facts CIK 1588978 CUSIP 74276L105 13F (30d) 250 filings 244 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)